GLP-1 Drugs Carry Eye Risk Warning

Cover art for GLP-1 Drugs Carry Eye Risk Warning

TL;DR: FDA adds NAION risk to GLP-1 drug warnings after studies show 2.6 extra cases per 100,000 users. FDA warns GLP-1 drugs may cause rare vision loss condition. The U.S. Food and Drug Administration announced on Nov. 9, 2026 that GLP-1 drugs carry a warning label for a rare eye condition that can cause vision loss.

Ziyad Al-Aly

From · · · 1m 30s

TL;DR: GLP-1 Drugs Carry Eye Risk Warning

FDA warns GLP-1 drugs may cause rare vision loss condition.

FDA adds NAION risk to GLP-1 drug warnings after studies show 2.6 extra cases per 100,000 users. FDA warns GLP-1 drugs may cause rare vision loss condition. The U.S. Food and Drug Administration announced on Nov. 9, 2026 that GLP-1 drugs carry a warning label for a rare eye condition that can cause vision loss.

  • FDA warns GLP-1 drugs
  • What is NAION?
  • How the link was found
  • FDA's risk analysis

Read the story version — the same reporting as a swipeable deck of 8 cards.

Read the original on The Conversation

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on non-arteritic anterior ischemic optic ne and related topics.